Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

Delayed Data
As of Feb 21
 +0.62 / +9.73%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 3.00. The median estimate represents a +0.14% increase from the last price of 6.99.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 32.56%
Growthannually 37.60%


Growthquarterly --
Growthannually -70.75%
Key to the earnings and sales forecast charts.